International Flavors & Fragrances, Inc (NYSE:IFF) Poised For Near-Term Upside On Valuation Gap

Momentum signals and a negative momentum/regression oscillator point toward a potential rebound while fundamentals show margin pressure and leverage that keep upside conditional. WMDST values the stock as under-valued, creating a price/valuation setup that swing traders should monitor closely.

Recent News

February 2026: Management launched a sale process for the Food Ingredients unit alongside a restructuring and portfolio-consolidation update announced in mid-February.

January 27, 2026: A class-action complaint tied to fragrance-product purchases filed in the District of New Jersey entered the public record.

February 2026: Several broker commentary notes reiterated positive operational themes and maintained upbeat ratings, citing margin recovery and portfolio simplification as drivers.

Technical Analysis

Directional indicators show DI+ at 23.91 with a dip & reversal, and DI- at 24.52 with a decreasing trend; those readings align toward short-term bullish pressure, though ADX at 14.4 signals no established trend and therefore limited directional conviction.

MACD sits at 0.10 above its signal line at -0.26, which constitutes a bullish cross; the MACD_trend registers a peak & reversal, indicating recent momentum has rolled over and suggesting the bullish cross may offer only a near-term lift unless momentum renews.

MRO at -4.98 with a dip & reversal indicates price below WMDST’s target and a mechanically higher probability of price appreciation toward valuation; that supports upside potential tied to the under-valued conclusion.

RSI of 50.88 with a peak & reversal shows neutral-to-slightly-fading relative strength, consistent with consolidation between short- and medium-term moving averages.

Price relationships provide contextual support: the close at $72.42 trades above the 200-day average ($68.90) but below the 50-day average ($74.50) and the 20-day average ($72.63), implying corrective trading inside a broader constructive range; SuperTrend lower support sits near $69.71 while Bollinger bands place the current range between about $71 and $75.

 


Fundamental Analysis

Revenue totaled $2,589,000,000 with revenue growth down 3.90% year-over-year but up 53.89% quarter-over-quarter, reflecting a sizable sequential pickup after annual weakness; that split suggests near-term operational improvement amid a still-contracting annual comparison.

EBIT registered $71,000,000 and an EBIT margin of 2.74%; that margin falls below the industry peer mean of 4.09% and below the industry peer median of 17.71%, while quarter-over-quarter EBIT margin declined roughly 28.96% and year-over-year moved down about 265.18%, reflecting compressive operating performance versus recent periods.

Operating margin stands at 4.365% with a QoQ contraction of 51.41% and YoY deterioration of 362.95%, indicating material near-term pressure on profitability despite efforts at portfolio optimization and cost control.

Profitability metrics show net income at $31,000,000 and return on equity near 0.22%, while return on assets sits at 0.12%; those low returns limit internal capital-generation velocity and amplify the importance of any successful divestiture proceeds.

Leverage metrics present elevated structural risk: total debt of $6,619,000,000, net debt of $5,404,000,000, and debt-to-EBITDA of 21.49x, with interest coverage roughly 1.45x—conditions that constrain margin for error and leave cash-flow conversion critical. Cash conversion cycle near 123 days runs longer than the industry peer mean of about 77 days, indicating working-capital intensity.

Market multiples carry mixed signals: P/E around 86.46x and price-to-book about 1.25x (below the industry peer mean book multiple of 5.72x and median of 7.89x), while enterprise multiple sits near 77.00. Free cash flow totaled $130,000,000 with a free cash flow yield near 0.74% and free-cash-growth showing negative YoY movement; those valuations align with WMDST’s assessment that the current valuation appears under-valued but vulnerable to execution risk.

EPS came in at $0.80 versus an estimate of $0.83, producing an EPS surprise of -3.61% that marginally undercut expectations; forward EPS implies a forward P/E near 54.69x and a negative forward PEG, reflecting low near-term growth assumptions embedded in consensus.

Valuation summary: WMDST values the stock as under-valued based on the gap between market multiples and the company’s adjusted cash-flow outlook, but margin compression, elevated leverage, and lengthening working capital amplify execution risk and make recovery dependent on successful portfolio moves and operating improvement.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2025-12-31
REPORT DATE: 2026-02-11
NEXT REPORT DATE: 2026-05-13
CASH FLOW  Begin Period Cash Flow 621.0 M
 Operating Cash Flow 318.0 M
 Capital Expenditures -188.00 M
 Change In Working Capital 106.0 M
 Dividends Paid -103.00 M
 Cash Flow Delta -31.00 M
 End Period Cash Flow 590.0 M
 
INCOME STATEMENT REVENUE
 Total Revenue 2.6 B
 Forward Revenue 6.4 B
COSTS
 Cost Of Revenue 1.7 B
 Depreciation -40.00 M
 Depreciation and Amortization 237.0 M
 Research and Development 174.0 M
 Total Operating Expenses 2.5 B
PROFITABILITY
 Gross Profit 890.0 M
 EBITDA 308.0 M
 EBIT 71.0 M
 Operating Income 113.0 M
 Interest Income
 Interest Expense 49.0 M
 Net Interest Income -49.00 M
 Income Before Tax 22.0 M
 Tax Provision -9.00 M
 Tax Rate 21.0 %
 Net Income 31.0 M
 Net Income From Continuing Operations 31.0 M
EARNINGS
 EPS Estimate 0.83
 EPS Actual 0.80
 EPS Difference -0.03
 EPS Surprise -3.614 %
 Forward EPS 1.19
 
BALANCE SHEET ASSETS
 Total Assets 25.5 B
 Intangible Assets 14.3 B
 Net Tangible Assets -158.00 M
 Total Current Assets 5.6 B
 Cash and Short-Term Investments 590.0 M
 Cash 590.0 M
 Net Receivables 1.7 B
 Inventory 2.4 B
 Long-Term Investments 516.0 M
LIABILITIES
 Accounts Payable 1.3 B
 Short-Term Debt 1.3 B
 Total Current Liabilities 3.9 B
 Net Debt 5.4 B
 Total Debt 6.6 B
 Total Liabilities 11.4 B
EQUITY
 Total Equity 14.2 B
 Retained Earnings -3.42 B
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 55.35
 Shares Outstanding 255.700 M
 Revenue Per-Share 10.13
VALUATION
 Market Capitalization 17.7 B
 Enterprise Value 23.7 B
 Enterprise Multiple 77.001
Enterprise Multiple QoQ 19.05 %
Enterprise Multiple YoY -34.958 %
Enterprise Multiple IPRWA high: 96.644
median: 85.541
IFF: 77.001
mean: 75.51
low: -33.169
 EV/R 9.16
CAPITAL STRUCTURE
 Asset To Equity 1.804
 Asset To Liability 2.25
 Debt To Capital 0.319
 Debt To Assets 0.259
Debt To Assets QoQ -0.173 %
Debt To Assets YoY 425.806 %
Debt To Assets IPRWA high: 0.595
median: 0.364
mean: 0.32
IFF: 0.259
low: 0.003
 Debt To Equity 0.468
Debt To Equity QoQ -0.453 %
Debt To Equity YoY 359.236 %
Debt To Equity IPRWA high: 2.027
median: 0.921
mean: 0.764
IFF: 0.468
low: 0.003
PRICE-BASED VALUATION
 Price To Book (P/B) 1.25
Price To Book QoQ 6.99 %
Price To Book YoY -22.514 %
Price To Book IPRWA high: 9.263
median: 7.894
mean: 5.718
IFF: 1.25
low: 0.272
 Price To Earnings (P/E) 86.465
Price To Earnings QoQ 39.886 %
Price To Earnings YoY -4.173 %
Price To Earnings IPRWA high: 308.977
median: 131.484
IFF: 86.465
mean: 76.775
low: -280.188
 PE/G Ratio -3.631
 Price To Sales (P/S) 6.832
Price To Sales QoQ 10.648 %
Price To Sales YoY -15.405 %
Price To Sales IPRWA high: 38.744
median: 18.382
mean: 15.518
IFF: 6.832
low: 1.224
FORWARD MULTIPLES
Forward P/E 54.695
Forward PE/G -2.297
Forward P/S 2.758
EFFICIENCY OPERATIONAL
 Operating Leverage 8.141
ASSET & SALES
 Asset Turnover Ratio 0.101
Asset Turnover Ratio QoQ -2.812 %
Asset Turnover Ratio YoY 6.703 %
Asset Turnover Ratio IPRWA high: 0.251
median: 0.173
mean: 0.156
IFF: 0.101
low: 0.004
 Receivables Turnover 1.438
Receivables Turnover Ratio QoQ -2.029 %
Receivables Turnover Ratio YoY -11.863 %
Receivables Turnover Ratio IPRWA high: 2.514
mean: 1.494
IFF: 1.438
median: 1.319
low: 0.211
 Inventory Turnover 0.706
Inventory Turnover Ratio QoQ 2.187 %
Inventory Turnover Ratio YoY -9.513 %
Inventory Turnover Ratio IPRWA high: 2.161
median: 1.553
mean: 1.305
IFF: 0.706
low: 0.104
 Days Sales Outstanding (DSO) 63.441
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 123.226
Cash Conversion Cycle Days QoQ 0.0 %
Cash Conversion Cycle Days YoY 15.167 %
Cash Conversion Cycle Days IPRWA high: 305.407
IFF: 123.226
mean: 77.689
median: 51.056
low: 25.374
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 1.559
 CapEx To Revenue -0.073
 CapEx To Depreciation 4.7
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 18.9 B
 Net Invested Capital 20.1 B
 Invested Capital 20.1 B
 Net Tangible Assets -158.00 M
 Net Working Capital 1.7 B
LIQUIDITY
 Cash Ratio 0.15
 Current Ratio 1.422
Current Ratio QoQ -1.508 %
Current Ratio YoY -22.896 %
Current Ratio IPRWA high: 5.668
mean: 1.745
IFF: 1.422
median: 1.076
low: 0.193
 Quick Ratio 0.821
Quick Ratio QoQ -2.489 %
Quick Ratio YoY -37.972 %
Quick Ratio IPRWA high: 3.941
mean: 1.197
IFF: 0.821
median: 0.807
low: 0.745
COVERAGE & LEVERAGE
 Debt To EBITDA 21.49
 Cost Of Debt 0.519 %
 Interest Coverage Ratio 1.449
Interest Coverage Ratio QoQ -33.124 %
Interest Coverage Ratio YoY -317.346 %
Interest Coverage Ratio IPRWA high: 27.334
median: 8.965
mean: 6.246
IFF: 1.449
low: -36.595
 Operating Cash Flow Ratio 0.126
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 68.558
DIVIDENDS
 Dividend Coverage Ratio 0.301
 Dividend Payout Ratio 3.323
 Dividend Rate 0.40
 Dividend Yield 0.006
PERFORMANCE GROWTH
 Asset Growth Rate -0.889 %
 Revenue Growth -3.898 %
Revenue Growth QoQ 53.889 %
Revenue Growth YoY -25.964 %
Revenue Growth IPRWA high: 18.339 %
median: 0.744 %
mean: 0.206 %
IFF: -3.898 %
low: -35.108 %
 Earnings Growth -23.81 %
Earnings Growth QoQ 173.804 %
Earnings Growth YoY 253.736 %
Earnings Growth IPRWA high: 47.368 %
median: 0.483 %
mean: -16.474 %
IFF: -23.81 %
low: -166.667 %
MARGINS
 Gross Margin 34.376 %
Gross Margin QoQ -5.788 %
Gross Margin YoY -2.799 %
Gross Margin IPRWA high: 45.15 %
median: 44.032 %
mean: 36.148 %
IFF: 34.376 %
low: -38.156 %
 EBIT Margin 2.742 %
EBIT Margin QoQ -28.964 %
EBIT Margin YoY -265.181 %
EBIT Margin IPRWA high: 19.701 %
median: 17.712 %
mean: 4.087 %
IFF: 2.742 %
low: -160.328 %
 Return On Sales (ROS) 4.365 %
Return On Sales QoQ -51.408 %
Return On Sales YoY -362.952 %
Return On Sales IPRWA high: 19.836 %
median: 18.746 %
mean: 14.089 %
IFF: 4.365 %
low: -62.942 %
CASH FLOW
 Free Cash Flow (FCF) 130.0 M
 Free Cash Flow Yield 0.735 %
Free Cash Flow Yield QoQ 308.333 %
Free Cash Flow Yield YoY -20.883 %
Free Cash Flow Yield IPRWA high: 3.973 %
mean: 1.224 %
median: 0.983 %
IFF: 0.735 %
low: -8.768 %
 Free Cash Growth 333.333 %
Free Cash Growth QoQ -519.54 %
Free Cash Growth YoY -1819.985 %
Free Cash Growth IPRWA IFF: 333.333 %
high: 164.557 %
median: 43.1 %
mean: 23.903 %
low: -136.967 %
 Free Cash To Net Income 4.194
 Cash Flow Margin 19.081 %
 Cash Flow To Earnings 15.935
VALUE & RETURNS
 Economic Value Added 0.03
 Return On Assets (ROA) 0.121 %
Return On Assets QoQ -21.429 %
Return On Assets YoY -177.07 %
Return On Assets IPRWA high: 2.61 %
median: 2.321 %
mean: 0.853 %
IFF: 0.121 %
low: -17.113 %
 Return On Capital Employed (ROCE) 0.329 %
 Return On Equity (ROE) 0.002
Return On Equity QoQ -22.064 %
Return On Equity YoY -165.964 %
Return On Equity IPRWA high: 0.058
median: 0.058
mean: 0.022
IFF: 0.002
low: -0.244
 DuPont ROE 0.218 %
 Return On Invested Capital (ROIC) 0.278 %
Return On Invested Capital QoQ -25.867 %
Return On Invested Capital YoY -107.221 %
Return On Invested Capital IPRWA high: 3.554 %
median: 3.554 %
mean: 1.771 %
IFF: 0.278 %
low: -18.25 %

Six-Week Outlook

Near-term price action should hinge on two forces: technicals that favor a bounce (DI+ dip & reversal, MRO negative with dip & reversal, MACD currently above its signal) and fundamentals that constrain sustained gains (thin margins, high leverage, stretched cash-conversion). Expect consolidation with a bias toward selective upside rallies that could test resistance around the 50-day average near $74.50; failure to regain that band would likely result in sideways-to-lower trade back toward the SuperTrend support near $69.71. Monitor progress on the Food Ingredients sale and any legal developments for catalysts that could materially alter the risk/return balance over the six-week horizon.

About International Flavors & Fragrances Inc.

International Flavors & Fragrances Inc. (NYSE:IFF) creates innovative solutions that enhance consumer experiences through scents, tastes, and nutrition. Headquartered in New York City, IFF operates through four main segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment develops natural and plant-based ingredients that enrich flavors in a variety of food and beverage products. Health & Biosciences focuses on producing enzymes, probiotics, and specialty ingredients that support both food and non-food industries, emphasizing health and sustainability. In the Scent division, IFF crafts fragrance compounds, including fine perfumes, consumer fragrances, and essential oils, which enhance personal care and household products. Pharma Solutions delivers innovative cellulosics and seaweed-based excipients for the pharmaceutical industry. Since its founding in 1909, IFF has committed to blending artistry with science, serving a diverse range of markets worldwide. By collaborating with manufacturers in cosmetics, food, beverages, and pharmaceuticals, IFF continues to inspire consumers while advancing industry standards and prioritizing sustainable practices to enhance well-being globally.



© 2026 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.